Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye

NCT01358266 is registered in ClinicalTrials.gov with Santen Inc. as lead sponsor.

NCT NCT01358266
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01358266 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Multinational, Multicenter, Randomized, Double-Masked, Study for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Lead sponsor
Santen Inc.
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2011
Completion date
December 31, 2016
Enrollment
592 (actual)
Sites
151

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis; posterior, disorder